Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TACROLIMUS vs TAFASITAMAB-CXIX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TACROLIMUS vs TAFASITAMAB-CXIX: Safety Overview

Metric TACROLIMUS TAFASITAMAB-CXIX
Total FAERS Reports 91,009 736
Deaths Reported 14,642 108
Death Rate 16.1% 14.7%
Hospitalizations 36,664 117
Average Patient Age 46.7 yrs 68.1 yrs
% Female Patients 44.1% 47.5%
FDA Approval Date Apr 16, 2018 N/A
Manufacturer Strides Pharma Science Limited N/A
Route ORAL N/A
Marketing Status Prescription Prescription